| 000 | 01459 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518011846.0 | ||
| 264 | 0 | _c20190610 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1471-2261 | ||
| 024 | 7 |
_a10.1186/s12872-018-0948-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Dong | |
| 245 | 0 | 0 |
_aCompared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis. _h[electronic resource] |
| 260 |
_bBMC cardiovascular disorders _c11 2018 |
||
| 300 |
_a217 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xblood |
| 650 | 0 | 4 |
_aClopidogrel _xadverse effects |
| 650 | 0 | 4 |
_aDyspnea _xchemically induced |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTicagrelor _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYang, Xiao-Hong | |
| 700 | 1 | _aZhang, Ji-Dong | |
| 700 | 1 | _aLi, Rui-Bin | |
| 700 | 1 | _aJia, Min | |
| 700 | 1 | _aCui, Xiao-Ran | |
| 773 | 0 |
_tBMC cardiovascular disorders _gvol. 18 _gno. 1 _gp. 217 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12872-018-0948-4 _zAvailable from publisher's website |
| 999 |
_c29111387 _d29111387 |
||